Compound Detail
CHEMBL4650281
CLN-081 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL4650281 |
| Name | CLN-081 |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | MKCYPWYURWOKST-INIZCTEOSA-N |
4
Targets
18
Activities
1
Assay Types
0
PK Parameters
8
Publications
8
Known Names
1
Indications
1
Mechanisms
Molecular Properties
396.4
MW (Da)
3.32
ALogP
6
HBA
2
HBD
98.7
PSA (Ų)
0.52
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Epidermal growth factor receptor erbB1 inhibitor | INHIBITOR | Epidermal growth factor receptor | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung
Activity Summary
IC50 18 meas. best 8.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | IC50 | 8.96 | 7.7057 | 1.1 | 7 |
| Unchecked CHEMBL612545 | IC50 | 8.3 | 8.3 | 5.0 | 4 |
| BaF3 CHEMBL614524 | IC50 | 8.3 | 7.59 | 5.0 | 3 |
| NIH3T3 CHEMBL614822 | IC50 | 7.63 | 7.0875 | 23.4 | 4 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38770784 | 10.1021/acs.jmedchem.4c00227 | Epidermal growth factor receptor | 12 |
| 38770784 | 10.1021/acs.jmedchem.4c00227 | Unchecked | 6 |
| 37669428 | 10.1021/acs.jmedchem.3c00875 | Unchecked | 5 |
| 37669428 | 10.1021/acs.jmedchem.3c00875 | NIH3T3 | 5 |
| 37669428 | 10.1021/acs.jmedchem.3c00875 | BaF3 | 3 |
| 37669428 | 10.1021/acs.jmedchem.3c00875 | Epidermal growth factor receptor | 2 |
| 36324498 | 10.1039/d2md00139j | Epidermal growth factor receptor | 1 |
| 38770784 | 10.1021/acs.jmedchem.4c00227 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine